Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Covington
UBS
Colorcon
QuintilesIMS
McKesson
Cipla
Dow
Argus Health

Generated: May 21, 2018

DrugPatentWatch Database Preview

Cupric chloride - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for cupric chloride and what is the scope of cupric chloride patent protection?

Cupric chloride
is the generic ingredient in one branded drug marketed by Hospira and is included in one NDA. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.
Summary for cupric chloride
Synonyms for cupric chloride
10125-13-0 (dihydrate)
423724-63-4
8309AF
AC1L2N5E
Additive Screening Solution 25/Fluka kit no 78374
AI3-01658
AKOS015902778
ANW-42299
BP-13443
CCRIS 6883
CHEBI:49553
Cl2Cu
Coclor
copper (II) cloride
copper (II)-chloride
copper (II)chloride
Copper atomic spectroscopy standard concentrate 1.00 g Cu
Copper atomic spectroscopy standard concentrate 1.00 g Cu, 1.00 g/L, for 1L standard solution, analytical standard
Copper bichloride
Copper chloride
Copper chloride (CuCl2)
Copper chloride (VAN)
Copper dichloride
Copper(2+) chloride
Copper(2+)chloride
Copper(II) chloride
Copper(II) chloride (1:2)
Copper(II) chloride 0.1 M solution
Copper(II) chloride, 97%
Copper(II) chloride, 99.999% trace metals basis
Copper(II) chloride, anhydrous
Copper(II) chloride, anhydrous, powder, >=99.995% trace metals basis
Copper(II) chloride, LR, >=98%
Copper(II) chloride, p.a., 97%
Copper(II) chloride, powder, 99%
Copper(II) chloride, SAJ first grade, >=98.0%
Copper(II) chloride, ultra dry
copper(II)-chloride
CTK8B3330
CuCl2
Cupric chloride anhydrous
Cupric chloride in plastic container
Cupric chloride solution
Cupric dichloride
D0M5YS
DB09131
dichlorocopper
EINECS 231-210-2
Epitope ID:156811
FT-0624119
HSDB 259
I14-19626
IN003519
IN015748
KB-296104
KSC913G3B
LS-54863
MolPort-003-925-260
NCI60_001274
NSC 165706
NSC-165706
NSC165706
ORTQZVOHEJQUHG-UHFFFAOYSA-L
RTR-024080
TRA0100984

US Patents and Regulatory Information for cupric chloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira CUPRIC CHLORIDE IN PLASTIC CONTAINER cupric chloride INJECTABLE;INJECTION 018960-001 Jun 26, 1986 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Chinese Patent Office
Federal Trade Commission
Harvard Business School
Cipla
Cerilliant
US Department of Justice
Johnson and Johnson
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.